MX2018011121A - Prevención de la adherencia de tejido biológico. - Google Patents

Prevención de la adherencia de tejido biológico.

Info

Publication number
MX2018011121A
MX2018011121A MX2018011121A MX2018011121A MX2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A MX 2018011121 A MX2018011121 A MX 2018011121A
Authority
MX
Mexico
Prior art keywords
biological tissue
self
tissue adhesion
assembling peptide
adhesion
Prior art date
Application number
MX2018011121A
Other languages
English (en)
Spanish (es)
Inventor
Kobayashi Satoru
Original Assignee
3 D Matrix Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 3 D Matrix Ltd filed Critical 3 D Matrix Ltd
Publication of MX2018011121A publication Critical patent/MX2018011121A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A61L31/047—Other specific proteins or polypeptides not covered by A61L31/044 - A61L31/046
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/043—Proteins; Polypeptides; Degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/145—Hydrogels or hydrocolloids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00743—Type of operation; Specification of treatment sites
    • A61B2017/00818—Treatment of the gastro-intestinal system
    • A61B2017/00823—Appendectomy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B17/00—Surgical instruments, devices or methods
    • A61B2017/00831—Material properties
    • A61B2017/00893—Material properties pharmaceutically effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Surgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Materials For Medical Uses (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
MX2018011121A 2016-03-18 2017-03-17 Prevención de la adherencia de tejido biológico. MX2018011121A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662310121P 2016-03-18 2016-03-18
US201662310131P 2016-03-18 2016-03-18
PCT/IB2017/000312 WO2017158420A1 (en) 2016-03-18 2017-03-17 Preventing biological tissue adhesion

Publications (1)

Publication Number Publication Date
MX2018011121A true MX2018011121A (es) 2019-01-31

Family

ID=58645327

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018011121A MX2018011121A (es) 2016-03-18 2017-03-17 Prevención de la adherencia de tejido biológico.

Country Status (11)

Country Link
US (4) US20190091376A1 (cg-RX-API-DMAC7.html)
EP (1) EP3429653B1 (cg-RX-API-DMAC7.html)
JP (1) JP7049557B2 (cg-RX-API-DMAC7.html)
KR (1) KR20190022455A (cg-RX-API-DMAC7.html)
CN (1) CN109152868A (cg-RX-API-DMAC7.html)
AU (2) AU2017232540A1 (cg-RX-API-DMAC7.html)
BR (1) BR112018068941A2 (cg-RX-API-DMAC7.html)
CA (1) CA3017684A1 (cg-RX-API-DMAC7.html)
CL (1) CL2018002646A1 (cg-RX-API-DMAC7.html)
MX (1) MX2018011121A (cg-RX-API-DMAC7.html)
WO (1) WO2017158420A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20190091376A1 (en) 2016-03-18 2019-03-28 3-D Matrix, Ltd. Preventing Biological Tissue Adhesion
CN112368295B (zh) 2018-07-03 2025-03-21 立美基股份有限公司 离子性自组装肽
CN115397454A (zh) 2020-03-31 2022-11-25 立美基股份有限公司 通过辐照对自组装肽进行灭菌
KR20250155730A (ko) * 2024-04-24 2025-10-31 경희대학교 산학협력단 하지정맥 수술시 정맥 내벽의 기계 화학적 절제장치

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2572964C (en) 2004-07-06 2018-03-06 3D Matrix, Inc. Purified amphiphilic peptide compositions and uses thereof
US9162005B2 (en) 2005-04-25 2015-10-20 Arch Biosurgery, Inc. Compositions for prevention of adhesions and other barrier applications
KR20100102750A (ko) * 2005-04-25 2010-09-24 메사추세츠 인스티튜트 오브 테크놀로지 지혈 및 다른 생리학적 활성을 촉진하기 위한 조성물 및 방법
CN105435211A (zh) * 2008-10-06 2016-03-30 三维肽胶株式会社 组织闭塞剂
JP6034868B2 (ja) * 2011-09-02 2016-11-30 株式会社スリー・ディー・マトリックス 胸部の空気漏れ閉塞のための両親媒性ペプチド
US20160287744A1 (en) * 2012-11-14 2016-10-06 3-D Matrix Ltd. Vascular embolic system
WO2014141160A1 (en) * 2013-03-14 2014-09-18 3-D Matrix, Ltd Treatment for bile leakage
US20190091376A1 (en) 2016-03-18 2019-03-28 3-D Matrix, Ltd. Preventing Biological Tissue Adhesion
CN109195640A (zh) 2016-03-18 2019-01-11 立美基股份有限公司 脑脊液漏堵塞
JP2019508175A (ja) 2016-03-18 2019-03-28 株式会社スリー・ディー・マトリックス 膵液瘻の閉鎖

Also Published As

Publication number Publication date
US20230241294A1 (en) 2023-08-03
US20250177614A1 (en) 2025-06-05
JP2019508184A (ja) 2019-03-28
AU2021225225A1 (en) 2021-09-30
US20220111126A1 (en) 2022-04-14
JP7049557B2 (ja) 2022-04-07
EP3429653B1 (en) 2022-11-09
CL2018002646A1 (es) 2019-07-05
US12377196B2 (en) 2025-08-05
KR20190022455A (ko) 2019-03-06
AU2017232540A1 (en) 2018-09-27
CN109152868A (zh) 2019-01-04
WO2017158420A1 (en) 2017-09-21
US20190091376A1 (en) 2019-03-28
CA3017684A1 (en) 2017-09-21
BR112018068941A2 (pt) 2019-04-16
EP3429653A1 (en) 2019-01-23

Similar Documents

Publication Publication Date Title
MX2021007434A (es) Peptidos de colageno producidos de forma sintetica y recombinante con eficacia biologica.
EP4349361A3 (en) Peptide exhibiting wrinkle-improving activity and uses thereof
PH12019501414A1 (en) Amino acid compositions and methods for the treatment of liver diseases
AU2018240515A1 (en) Nucleic acids encoding CRISPR-associated proteins and uses thereof
PH12020500321A1 (en) Amino acid compositions for the treatment of liver disease
MX2018011120A (es) Oclusion de fistula pancreatica.
HK1220145A1 (zh) 胆漏治疗
WO2018068947A3 (de) Proteinhydrolysate
MX2021008207A (es) Proteínas de fusión multifuncionales y usos de las mismas.
EP3606570B8 (en) Collagen peptide-based medicament compositions for use in the treatment of ocular diseases, disorders or wounds
EA202191686A1 (ru) Гидролизат коллагена для применения против кожных болезней и кишечных заболеваний
EP3501532A3 (en) Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
AU2018236629A8 (en) Hydrogel patch
EP3590338A3 (en) Medical treatments based on anamorelin
PH12017501304A1 (en) Levodopa and carbidopa intestinal gel and method of use
WO2019043649A3 (en) ANGIO -3 FOR THE TREATMENT OF RETINAL ANGIOGENIC DISEASES
MX2019005979A (es) Peptidos modificados.
WO2016073443A3 (en) Peripheral kappa opioid receptor agonists for hard tissue pain
CL2018002646A1 (es) Prevención de la adherencia del tejido biológico.
MX2018011082A (es) Péptido o aminoácido n-lipoico, derivados y sus usos.
ZA202002107B (en) Use of specific sirna against protein s for the treatment of hemophilia
MX2018011201A (es) Oclusion de fuga de liquido cefalorraquideo.
EP4272830A3 (en) Tissue organoids
ZA202201468B (en) Method
EP4257128A3 (en) Methods and compounds for the treatment of genetic disease